May 10 |
How A Top Fund Beats The Market By Owning Future Leaders
|
May 10 |
Innovent’s mazdutide superior to Trulicity in Phase III T2D trial
|
May 10 |
Zacks Investment Ideas feature highlights: Eaton, Eli Lilly and Arista Networks
|
May 10 |
UPDATE 2-India's Cipla open to partnering with Eli Lilly to market their obesity drugs, CEO says
|
May 9 |
3 Stocks to Buy Following Guidance Upgrades
|
May 9 |
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q1 2024 Earnings Call Transcript
|
May 9 |
Lilly next-generation diabetes drug mazdutide meets primary goal in phase 3 trial
|
May 9 |
Making Money Off the Weight-Loss Revolution Has Even Wall Street Befuddled
|
May 9 |
Q1 2024 Amphastar Pharmaceuticals Inc Earnings Call
|
May 8 |
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
|